Effects of antipsychotic drugs on operant responding after acute and repeated administration
The current generation of atypical antipsychotic drugs represents an improvement over traditional ("typical") antipsychotics in many respects. However, a theoretical framework and adequate preclinical models have not yet been developed to predict or explain differences among the atypical a...
Gespeichert in:
Veröffentlicht in: | Psychopharmacologia 2002-03, Vol.160 (2), p.182-191 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 191 |
---|---|
container_issue | 2 |
container_start_page | 182 |
container_title | Psychopharmacologia |
container_volume | 160 |
creator | VARVEL, S. A VANN, R. E WISE, L. E PHILIBIN, S. D PORTER, J. H |
description | The current generation of atypical antipsychotic drugs represents an improvement over traditional ("typical") antipsychotics in many respects. However, a theoretical framework and adequate preclinical models have not yet been developed to predict or explain differences among the atypical antipsychotics, a necessary component of future development.
The purpose of the present set of experiments was to identify differences between the acute and subchronic effects of several atypical antipsychotic drugs and the typical antipsychotic haloperidol on operant responding in rats.
The effects of haloperidol and the atypical antipsychotics clozapine, olanzapine, risperidone, sertindole, quetiapine, remoxipride, and thioridazine were determined in rats trained to respond for food reward under a multiple fixed ratio 30/fixed interval 60 s schedule. A profile of the acute effects of each drug on response rates, response durations, and within-session effects were determined. Next, the dose of each drug that produced 75% suppression of response rates was administered for 16 consecutive days to determine whether or not tolerance would develop to the rate-suppressing effects of that dose.
All drugs produced dose-related decreases in response rates. Only haloperidol and risperidone produced significant increases in response duration, while only haloperidol and remoxipride displayed within-session response decrements. Tolerance was evident for clozapine and to a lesser extent thioridazine.
These results illustrate that the current generation of atypical antipsychotics are a heterogeneous group and that operant procedures may be useful for identifying differences preclinically. Specifically, clozapine appears to possess properties that distinguish it from other atypical antipsychotics, particularly after repeated dosing. |
doi_str_mv | 10.1007/s00213-001-0969-y |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71497602</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>737974331</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-4e94a40bdd19e6b826429fdab94f116f0bb54ba28b379049e87b461a72b86f7e3</originalsourceid><addsrcrecordid>eNqFkU1rFTEUhoNU7LX6A9zIUKi7sTlJJh9LKa0KBTe6K4R81pR7J2OSWdx_39R7odBNswnkPO855DwIfQL8FTAWlxVjAnTEGEasuBr3b9AGGCUjwYKcoA3GlI4UJnmK3tf6gPthkr1DpwBSTJzyDbq7jjG4VoccBzO3tNS9-5tbcoMv631_noe8hNJLQwl1ybNP8_1gYgtlMG5toad8Ly3BtOAH43dpTrUV01KeP6C30Wxr-Hi8z9Cfm-vfVz_G21_ff159ux0dlVMbWVDMMGy9BxW4lYQzoqI3VrEIwCO2dmLWEGmpUJipIIVlHIwgVvIoAj1DXw59l5L_raE2vUvVhe3WzCGvVQtgSnBMXgVBUi4kYR08fwE-5LXM_ROagOy7nv5DcIBcybWWEPVS0s6UvQasnwTpgyDdBeknQXrfM5-PjVe7C_45cTTSgYsjYKoz29hX71J95mifzIHSR0b_mRE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>218969524</pqid></control><display><type>article</type><title>Effects of antipsychotic drugs on operant responding after acute and repeated administration</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>VARVEL, S. A ; VANN, R. E ; WISE, L. E ; PHILIBIN, S. D ; PORTER, J. H</creator><creatorcontrib>VARVEL, S. A ; VANN, R. E ; WISE, L. E ; PHILIBIN, S. D ; PORTER, J. H</creatorcontrib><description>The current generation of atypical antipsychotic drugs represents an improvement over traditional ("typical") antipsychotics in many respects. However, a theoretical framework and adequate preclinical models have not yet been developed to predict or explain differences among the atypical antipsychotics, a necessary component of future development.
The purpose of the present set of experiments was to identify differences between the acute and subchronic effects of several atypical antipsychotic drugs and the typical antipsychotic haloperidol on operant responding in rats.
The effects of haloperidol and the atypical antipsychotics clozapine, olanzapine, risperidone, sertindole, quetiapine, remoxipride, and thioridazine were determined in rats trained to respond for food reward under a multiple fixed ratio 30/fixed interval 60 s schedule. A profile of the acute effects of each drug on response rates, response durations, and within-session effects were determined. Next, the dose of each drug that produced 75% suppression of response rates was administered for 16 consecutive days to determine whether or not tolerance would develop to the rate-suppressing effects of that dose.
All drugs produced dose-related decreases in response rates. Only haloperidol and risperidone produced significant increases in response duration, while only haloperidol and remoxipride displayed within-session response decrements. Tolerance was evident for clozapine and to a lesser extent thioridazine.
These results illustrate that the current generation of atypical antipsychotics are a heterogeneous group and that operant procedures may be useful for identifying differences preclinically. Specifically, clozapine appears to possess properties that distinguish it from other atypical antipsychotics, particularly after repeated dosing.</description><identifier>ISSN: 0033-3158</identifier><identifier>EISSN: 1432-2072</identifier><identifier>DOI: 10.1007/s00213-001-0969-y</identifier><identifier>PMID: 11875636</identifier><identifier>CODEN: PSYPAG</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Animals ; Antipsychotic Agents - pharmacology ; Antipsychotics ; Benzodiazepines ; Biological and medical sciences ; Clozapine - pharmacology ; Conditioning, Operant - drug effects ; Dibenzothiazepines - pharmacology ; Dose-Response Relationship, Drug ; Drug dosages ; Haloperidol - pharmacology ; Imidazoles - pharmacology ; Indoles - pharmacology ; Male ; Medical sciences ; Neuropharmacology ; Pharmacology. Drug treatments ; Pirenzepine - analogs & derivatives ; Pirenzepine - pharmacology ; Psycholeptics: tranquillizer, neuroleptic ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Psychotropic drugs ; Quetiapine Fumarate ; Rats ; Rats, Sprague-Dawley ; Remoxipride - pharmacology ; Response rates ; Risperidone - pharmacology ; Schedules ; Thioridazine - pharmacology ; Time Factors</subject><ispartof>Psychopharmacologia, 2002-03, Vol.160 (2), p.182-191</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright Springer-Verlag 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-4e94a40bdd19e6b826429fdab94f116f0bb54ba28b379049e87b461a72b86f7e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13524613$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11875636$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VARVEL, S. A</creatorcontrib><creatorcontrib>VANN, R. E</creatorcontrib><creatorcontrib>WISE, L. E</creatorcontrib><creatorcontrib>PHILIBIN, S. D</creatorcontrib><creatorcontrib>PORTER, J. H</creatorcontrib><title>Effects of antipsychotic drugs on operant responding after acute and repeated administration</title><title>Psychopharmacologia</title><addtitle>Psychopharmacology (Berl)</addtitle><description>The current generation of atypical antipsychotic drugs represents an improvement over traditional ("typical") antipsychotics in many respects. However, a theoretical framework and adequate preclinical models have not yet been developed to predict or explain differences among the atypical antipsychotics, a necessary component of future development.
The purpose of the present set of experiments was to identify differences between the acute and subchronic effects of several atypical antipsychotic drugs and the typical antipsychotic haloperidol on operant responding in rats.
The effects of haloperidol and the atypical antipsychotics clozapine, olanzapine, risperidone, sertindole, quetiapine, remoxipride, and thioridazine were determined in rats trained to respond for food reward under a multiple fixed ratio 30/fixed interval 60 s schedule. A profile of the acute effects of each drug on response rates, response durations, and within-session effects were determined. Next, the dose of each drug that produced 75% suppression of response rates was administered for 16 consecutive days to determine whether or not tolerance would develop to the rate-suppressing effects of that dose.
All drugs produced dose-related decreases in response rates. Only haloperidol and risperidone produced significant increases in response duration, while only haloperidol and remoxipride displayed within-session response decrements. Tolerance was evident for clozapine and to a lesser extent thioridazine.
These results illustrate that the current generation of atypical antipsychotics are a heterogeneous group and that operant procedures may be useful for identifying differences preclinically. Specifically, clozapine appears to possess properties that distinguish it from other atypical antipsychotics, particularly after repeated dosing.</description><subject>Animals</subject><subject>Antipsychotic Agents - pharmacology</subject><subject>Antipsychotics</subject><subject>Benzodiazepines</subject><subject>Biological and medical sciences</subject><subject>Clozapine - pharmacology</subject><subject>Conditioning, Operant - drug effects</subject><subject>Dibenzothiazepines - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug dosages</subject><subject>Haloperidol - pharmacology</subject><subject>Imidazoles - pharmacology</subject><subject>Indoles - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pirenzepine - analogs & derivatives</subject><subject>Pirenzepine - pharmacology</subject><subject>Psycholeptics: tranquillizer, neuroleptic</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Psychotropic drugs</subject><subject>Quetiapine Fumarate</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Remoxipride - pharmacology</subject><subject>Response rates</subject><subject>Risperidone - pharmacology</subject><subject>Schedules</subject><subject>Thioridazine - pharmacology</subject><subject>Time Factors</subject><issn>0033-3158</issn><issn>1432-2072</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkU1rFTEUhoNU7LX6A9zIUKi7sTlJJh9LKa0KBTe6K4R81pR7J2OSWdx_39R7odBNswnkPO855DwIfQL8FTAWlxVjAnTEGEasuBr3b9AGGCUjwYKcoA3GlI4UJnmK3tf6gPthkr1DpwBSTJzyDbq7jjG4VoccBzO3tNS9-5tbcoMv631_noe8hNJLQwl1ybNP8_1gYgtlMG5toad8Ly3BtOAH43dpTrUV01KeP6C30Wxr-Hi8z9Cfm-vfVz_G21_ff159ux0dlVMbWVDMMGy9BxW4lYQzoqI3VrEIwCO2dmLWEGmpUJipIIVlHIwgVvIoAj1DXw59l5L_raE2vUvVhe3WzCGvVQtgSnBMXgVBUi4kYR08fwE-5LXM_ROagOy7nv5DcIBcybWWEPVS0s6UvQasnwTpgyDdBeknQXrfM5-PjVe7C_45cTTSgYsjYKoz29hX71J95mifzIHSR0b_mRE</recordid><startdate>20020301</startdate><enddate>20020301</enddate><creator>VARVEL, S. A</creator><creator>VANN, R. E</creator><creator>WISE, L. E</creator><creator>PHILIBIN, S. D</creator><creator>PORTER, J. H</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20020301</creationdate><title>Effects of antipsychotic drugs on operant responding after acute and repeated administration</title><author>VARVEL, S. A ; VANN, R. E ; WISE, L. E ; PHILIBIN, S. D ; PORTER, J. H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-4e94a40bdd19e6b826429fdab94f116f0bb54ba28b379049e87b461a72b86f7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Antipsychotic Agents - pharmacology</topic><topic>Antipsychotics</topic><topic>Benzodiazepines</topic><topic>Biological and medical sciences</topic><topic>Clozapine - pharmacology</topic><topic>Conditioning, Operant - drug effects</topic><topic>Dibenzothiazepines - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug dosages</topic><topic>Haloperidol - pharmacology</topic><topic>Imidazoles - pharmacology</topic><topic>Indoles - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pirenzepine - analogs & derivatives</topic><topic>Pirenzepine - pharmacology</topic><topic>Psycholeptics: tranquillizer, neuroleptic</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Psychotropic drugs</topic><topic>Quetiapine Fumarate</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Remoxipride - pharmacology</topic><topic>Response rates</topic><topic>Risperidone - pharmacology</topic><topic>Schedules</topic><topic>Thioridazine - pharmacology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VARVEL, S. A</creatorcontrib><creatorcontrib>VANN, R. E</creatorcontrib><creatorcontrib>WISE, L. E</creatorcontrib><creatorcontrib>PHILIBIN, S. D</creatorcontrib><creatorcontrib>PORTER, J. H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Psychopharmacologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VARVEL, S. A</au><au>VANN, R. E</au><au>WISE, L. E</au><au>PHILIBIN, S. D</au><au>PORTER, J. H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of antipsychotic drugs on operant responding after acute and repeated administration</atitle><jtitle>Psychopharmacologia</jtitle><addtitle>Psychopharmacology (Berl)</addtitle><date>2002-03-01</date><risdate>2002</risdate><volume>160</volume><issue>2</issue><spage>182</spage><epage>191</epage><pages>182-191</pages><issn>0033-3158</issn><eissn>1432-2072</eissn><coden>PSYPAG</coden><abstract>The current generation of atypical antipsychotic drugs represents an improvement over traditional ("typical") antipsychotics in many respects. However, a theoretical framework and adequate preclinical models have not yet been developed to predict or explain differences among the atypical antipsychotics, a necessary component of future development.
The purpose of the present set of experiments was to identify differences between the acute and subchronic effects of several atypical antipsychotic drugs and the typical antipsychotic haloperidol on operant responding in rats.
The effects of haloperidol and the atypical antipsychotics clozapine, olanzapine, risperidone, sertindole, quetiapine, remoxipride, and thioridazine were determined in rats trained to respond for food reward under a multiple fixed ratio 30/fixed interval 60 s schedule. A profile of the acute effects of each drug on response rates, response durations, and within-session effects were determined. Next, the dose of each drug that produced 75% suppression of response rates was administered for 16 consecutive days to determine whether or not tolerance would develop to the rate-suppressing effects of that dose.
All drugs produced dose-related decreases in response rates. Only haloperidol and risperidone produced significant increases in response duration, while only haloperidol and remoxipride displayed within-session response decrements. Tolerance was evident for clozapine and to a lesser extent thioridazine.
These results illustrate that the current generation of atypical antipsychotics are a heterogeneous group and that operant procedures may be useful for identifying differences preclinically. Specifically, clozapine appears to possess properties that distinguish it from other atypical antipsychotics, particularly after repeated dosing.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>11875636</pmid><doi>10.1007/s00213-001-0969-y</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0033-3158 |
ispartof | Psychopharmacologia, 2002-03, Vol.160 (2), p.182-191 |
issn | 0033-3158 1432-2072 |
language | eng |
recordid | cdi_proquest_miscellaneous_71497602 |
source | MEDLINE; Springer Nature - Complete Springer Journals |
subjects | Animals Antipsychotic Agents - pharmacology Antipsychotics Benzodiazepines Biological and medical sciences Clozapine - pharmacology Conditioning, Operant - drug effects Dibenzothiazepines - pharmacology Dose-Response Relationship, Drug Drug dosages Haloperidol - pharmacology Imidazoles - pharmacology Indoles - pharmacology Male Medical sciences Neuropharmacology Pharmacology. Drug treatments Pirenzepine - analogs & derivatives Pirenzepine - pharmacology Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopharmacology Psychotropic drugs Quetiapine Fumarate Rats Rats, Sprague-Dawley Remoxipride - pharmacology Response rates Risperidone - pharmacology Schedules Thioridazine - pharmacology Time Factors |
title | Effects of antipsychotic drugs on operant responding after acute and repeated administration |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T10%3A11%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20antipsychotic%20drugs%20on%20operant%20responding%20after%20acute%20and%20repeated%20administration&rft.jtitle=Psychopharmacologia&rft.au=VARVEL,%20S.%20A&rft.date=2002-03-01&rft.volume=160&rft.issue=2&rft.spage=182&rft.epage=191&rft.pages=182-191&rft.issn=0033-3158&rft.eissn=1432-2072&rft.coden=PSYPAG&rft_id=info:doi/10.1007/s00213-001-0969-y&rft_dat=%3Cproquest_cross%3E737974331%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=218969524&rft_id=info:pmid/11875636&rfr_iscdi=true |